Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Total Liabilities (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Total Liabilities data on record, last reported at $191.9 million in Q2 2025.

  • For Q2 2025, Total Liabilities fell 4.07% year-over-year to $191.9 million; the TTM value through May 2025 reached $191.9 million, down 4.07%, while the annual FY2025 figure was $191.9 million, 4.07% down from the prior year.
  • Total Liabilities reached $191.9 million in Q2 2025 per LFCR's latest filing, up from $190.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $305.2 million in Q1 2021 and bottomed at $163.4 million in Q1 2023.
  • Average Total Liabilities over 5 years is $217.0 million, with a median of $201.8 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: tumbled 40.03% in 2022, then rose 16.75% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $265.9 million in 2021, then decreased by 22.96% to $204.8 million in 2022, then fell by 0.66% to $203.5 million in 2023, then decreased by 3.86% to $195.6 million in 2024, then dropped by 1.9% to $191.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $191.9 million in Q2 2025, $190.3 million in Q1 2025, and $195.6 million in Q4 2024.